1.Name：Jur-Shan Cheng
2.Institution：Chang Gung University
3.Position：Assistant Professor
4.Department：Clinical Informatics and Medical Statistics Research Center
5.Address：No.259, Wenhua 1st Rd., Guishan Dist., Taoyuan City 33302, Taiwan (R.O.C.)
6.Tel(GSM optional)/Fax：+886-3-211-8800#3810 / +886-3-2118453
7.E-mail：jscheng@mail.cgu.edu.tw
8.Personal Website：
9.Focus of Interest：Health Economics
10.Fulltime Employment：
National Health Research Institutes, Institute of Population Health, Postdoctoral Research Fellow
11.Education：
Ph.D. in Health Services and Policy Analysis, University of California at Berkeley
12.Honors and Awards
13.SelectedMain Publications（up to 5 ）：
(1)Cheng JS, Tsai WC, Lin CL, Chen L, Lang HC, Hsieh HM, Shin SJ, Chen T, Huang CT, Hsu CC. Trend and Factors Associated With Healthcare Use and Costs in Type 2 Diabetes Mellitus: A Decade Experience of a Universal Health Insurance Program. Med Care. 2015 Feb;53(2):116-124.
(2)Hsu CC, Lee CH, Wahlqvist ML, Huang HL, Chang HY, Chen L, Shih SF, Shin SJ, Tsai WC, Chen T, Huang CT, Cheng JS*. Poverty increases type 2 diabetes incidence and inequality of care despite universal health coverage. Diabetes Care 2012 Nov;35(11):2286-92.
14.Patents：None
15.Board Certification：
Taiwan Society for Pharmacoeconomics and Outcome Research
16.Ongoing projects：
Medical care and costs of systemic lupus erythematosus (2015/08/01-2016/07/31)
17.All publications：
1. Hsu JY, Chang CJ, Cheng JS. Survival, treatment regimens and medical costs of women newly diagnosed with metastatic triple-negative breast cancer. Sci Rep. 2022;12(1):729.
2. Cheng JS, Chen TC, Chen TD, Ku HP, Huang SW, Wu TS, Chien RN, Chang ML. Association between breast cancer and hepatitis C: A joint study of hospitalized patients and nationwide cohorts. Transl Res. 2022;245:117-129.
3.Chang ML, Cheng JS, Chuang YH, Pao LH, Wu TS, Chen SC, Chang MY, Chien RN. Evolution of Cryoglobulinemia in Direct-Acting Antiviral-Treated Asian Hepatitis C Patients With Sustained Virological Responses: A 4-Year Prospective Cohort Study. Front Immunol. 2022;13:823160.
4. Tsai CC, Chen YL, Lu CS, Cheng JS, Weng YH, Lin SH, Wu YM, Wang JJ. Diffusion Tensor Imaging for the differential diagnosis of Parkinsonism by machine learning. Biomed J. 2022:S2319-4170(22)00091-9.
5. Oh SL, Chen CM, Wu YR, Valdes Hernandez M, Tsai CC, Cheng JS, Chen YL, Wu YM, Lin YC, Wang JJ. Fixel-Based Analysis Effectively Identifies White Matter Tract Degeneration in Huntington's Disease. Front Neurosci. 2021;15:711651.
6. Chen CJ, Cheng JS, Wang HE, Huang CW, Hu JH, Chen WT, Chang MY, Ku HP, Lin CY, Chien RN, Chang ML. Identification of the Representative Primary Biliary Cholangitis Cohort in Taiwan: A Comparison of Four Nationwide Cohorts. J Clin Med. 2021;10(11):2226.
7.Cheng JS, Hu JH, Chang MY, Lin MS, Ku HP, Chien RN, Chang ML. Hepatitis C-associated late-onset schizophrenia: a nationwide, population-based cohort study. J Psychiatry Neurosci. 2021;46(6):E583-E591.
8.Cheng JS, Lin YS, Hu JH, Chang MY, Ku HP, Chien RN, Chang ML. Impact of Interferon-Based Therapy on Hepatitis C-Associated Rheumatic Diseases: A Nationwide Population-Based Cohort Study. J Clin Med. 2021;10(4):817.
9. Chu YY, Cheng JS, Wu TS, Chen CW, Chang MY, Ku HP, Chien RN, Chang ML. Association between Hepatitis C Virus Infection and Esophageal Cancer: An Asian Nationwide Population-Based Cohort Study. J Clin Med. 2021;10(11):2395.
10.Nguyen TT, Cheng JS, Chen YL, Lin YC, Tsai CC, Lu CS, Weng YH, Wu YM, Hoang NT, Wang JJ. Fixel-Based Analysis of White Matter Degeneration in Patients With Progressive Supranuclear Palsy or Multiple System Atrophy, as Compared to Parkinson's Disease. Front Aging Neurosci. 2021;13:625874.
11.Wu MH, Lin YS, Wu C, Lee CY, Chen YC, Huang TJ, Cheng JS. Timing of Bisphosphonate (Alendronate) Initiation after Surgery for Fragility Fracture: A Population-Based Cohort Study. J Clin Med. 2021 Jun 8;10(12):2541.
